# PPD Development, L.P. – FDA Inspection, Sep 25, 2025

Source: https://www.keypedia.com/records/fda_inspections/ppd-development-lp/b5b40b46-bc35-4341-ab56-8360b5d286c7
Source feed: FDA_Inspections

> FDA inspection 1284012 of PPD Development, L.P., September 25, 2025. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1284012
- Company Name: PPD Development, L.P.
- Inspection Date: 2025-09-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Minneapolis District Office
- Citation Count: 3

## Related Documents

- FDA Inspection 1320960 - 2026-05-01
- [FDA Inspection 1202015 - 2023-04-05](https://www.keypedia.com/records/fda_inspections/ppd-development-lp/61385a36-2db6-4cf0-ad66-26d7e6159aa0)
- FDA Inspection 1146503 - 2021-07-16
- FDA Inspection 1105196 - 2019-09-19
- [FDA Inspection 1056412 - 2018-05-18](https://www.keypedia.com/records/fda_inspections/ppd-development-lp/a09fb41c-bfb2-4bd5-9a29-33af8b2a7061)

## Related Officers

- [Investigator](https://www.keypedia.com/people/beatrix-d-hippe/4a5a5258-3099-46cd-9e56-2dce60668ac5)
- [Investigator](https://www.keypedia.com/people/eric-d-bowles/bb6c783b-0933-4231-b79e-c591cbc50104)
- [Issuing Officer](https://www.keypedia.com/people/jean-claude-garay/e85f215e-5a7e-40f7-9214-74b18de1792a)

Company: https://www.keypedia.com/companies/ppd-development-lp/0d495b78-4879-42fc-8887-4e0294e69720

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d
